How Much Weight Can You Lose on Mounjaro or Wegovy?

Both Mounjaro and Wegovy are GLP-1 receptor agonist medicines prescribed to support weight management alongside dietary change and increased activity. Mounjaro additionally acts on GIP receptors, giving it a dual mechanism. Neither medicine works in isolation — results reflect the whole picture.

Why results vary so much

Several factors shape how much weight any individual loses:

• Starting weight and body composition — people with higher starting weights often see larger absolute losses, though percentage changes vary too.
• Dose stage — both medicines are started at a low dose and adjusted over time by your prescriber. Results at an early dose stage (such as 2.5 mg or 5 mg of tirzepatide, or 0.25 mg of semaglutide) are typically more modest than at higher maintenance doses, simply because the dose is building up.
• Consistency — missing doses or irregular injection timing can affect how steadily the medicine acts.
• Food and activity — the medicines work best when supported by protein-focused eating, adequate hydration, and regular movement.
• Individual biology — response to GLP-1 and GIP pathways differs between people.

Early stages versus higher doses

At an introductory dose such as 2.5 mg of Mounjaro, the primary purpose is tolerability — your body is adjusting. Weight change at this stage is often smaller. As your prescriber increases the dose over subsequent weeks, many people report that appetite reduction and weight loss become more noticeable. The same pattern applies with Wegovy's titration schedule. All dose decisions remain with your prescriber.

Is weekly loss a useful measure?

Week-to-week changes on the scale can be misleading — water retention, hormonal fluctuations, and normal biological variation all move the number. Day-to-day weight changes are even noisier. Most clinicians and the people who track carefully find that looking at trends over several weeks gives a far more useful picture than any single weigh-in. You can read more about realistic individual expectations on Mounjaro and what patterns people commonly see over time.

Progress also is not just the scale — energy, mood, measurements, and how clothes fit are all part of the story. For a broader look at the weight-loss journey on GLP-1 medicines, see our guide to weight loss on GLP-1 medicines.

One of the most practical things you can do on a GLP-1 journey is build a reliable record of your progress over time — not just the headline number, but the full picture. GLP Trackr's weight and body tracking feature lets you log your weight regularly and see it rendered as a trend chart, so short-term fluctuations stop feeling alarming and genuine progress becomes visible.

Beyond the scale, the weekly transformation view pulls together weight, measurements, and wellbeing data — mood, energy, sleep, and food-noise levels logged in your daily check-in — so you can see what's actually shifting across your whole journey, not just one metric. The insights and analytics layer goes further: a plateau forecast and correlation explorer help you spot patterns between your habits and your results, turning scattered data points into something genuinely useful to discuss with your prescriber.

GLP Trackr supports both Mounjaro and Wegovy users, at every dose stage.

A note on results: GLP Trackr helps you observe and understand your own patterns — it does not predict clinical outcomes, and no app or article can tell you exactly how much weight you will lose. Your prescriber is best placed to set realistic expectations based on your full health history. If progress feels stalled or you have concerns about your treatment, talk to your healthcare professional rather than adjusting anything on your own.

Start building a clearer picture of your journey today — GLP Trackr is free to try for 7 days on the App Store and Google Play. Download it free on iOS or Android and see your progress in one place.